Kendalee Olmo Diaz in

Kendalee Olmo Diaz

Inquirer · DISC type cd
U.S Commercial Lead Biosimilar Portfolio – Strategy & Marketing at Sandoz
📍 United States

Kendalee Olmo Diaz is a biopharma industry leader with extensive experience in marketing and commercialization, particularly in oncology and biosimilars. Her career includes leadership roles at Sandoz, Sanofi, and Amgen, where she has led successful U. S. and global product launches. Colleagues describe her as strategic, detail-oriented, and a strong, communicative leader.

She appears to be driven by a sense of purpose beyond ambition, as reflected in her shared content about making a deeper, more human impact. Her focus extends to advancing patient access to innovative medicines, a theme that consistently appears in her professional mission and social media activity.

Unique fact: While at Teva, she led a strategic reassessment of a major brand that doubled its net present value and increased projected earnings by 30%.

Read the full overview →
Experience
4 Years
Current Role
U.S Commercial Lead Biosimilar Portfolio – Strategy & Marketing
Job Level
Junior
Location
United States
Personality Overview

How Kendalee shows up

Demanding
Hard To Convince
ROI Conscious

They focus on objectivity in a pitch and pay little attention to bells and whistles. They don’t always try to control the conversation but neither do they like yielding it fully. They respond well to confident salespeople.

Priorities

Topics Kendalee cares about

Biosimilar Strategy
Her current role at Sandoz and past role at Teva focus on leading commercial and marketing strategy for biosimilar portfolios.
Oncology Marketing
She has a proven record of leading U. S. and global marketing launches for major oncology therapies at companies like Sanofi and Amgen.
+5 more topics Login to view topics
Career

Work history

8-2025
U.S Commercial Lead Biosimilar Portfolio – Strategy & Marketing
Sandoz
1-2025
Founder- INVENIO. The Art Of Building What’s Next
INVENIO
5-2023 - 7-2024
Brand and Portfolio Strategy & Launch Lead, Biosimilars
Teva Pharmaceuticals
9-2020 - 8-2022
U.S. Launch Lead - Marketing Director | Oncology
Sanofi
7-2019 - 4-2020
Global Oncology Strategy & Launch, Director
Amgen
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2-2022 - 5-2022
Strategic Leadership Development: Building Executive Presence and Influence
Wharton Executive Education
1-2025 - 5-2025
Career Advancement Program
Rutgers Business School
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Sandoz Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Kendalee. Free, 10 seconds.